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CHAPTER 1. General Introduction 
 
Itk and Tec Family Tyrosine Kinases 
Tec family non-receptor tyrosine kinases are among the key regulators in the 
lymphocyte signaling pathway. The Tec kinase family contains five members: Itk, Btk, 
Tec, Rlk and Bmx (Lucas et al., 2003). In mammals, Tec kinases are mainly 
expressed in cells of the hematopoietic system and also in cells from myeloid 
lineages, including mast cells, platelets, macrophages, neutrophils and dendritic cells 
(Schmidt et al., 2004). Interleukin-2 tyrosine kinase (or inducible T-cell tyrosine 
kinase), Itk, is an important member of the Tec family tyrosine kinases, the second 
largest non-receptor tyrosine kinase family. Itk is expressed at the level of mRNA in 
naive mouse T cells, while Rlk and Tec are expressed at much lower levels in these 
cells (Lucas et al., 2003; Colgan et al., 2004). Btk is the earliest discovered Tec family 
kinase because it is linked to X-linked immunodeficiency (Xid) and X-linked 
agammaglobulinemia (XLA), heritable immunodeficiency disorder diseases. Btk 
deficiency or mutation causes B cell development deficiency and therefore leads to 
Xid and XLA (Schaeffer and Schwartzberg, 2000). Mutations leading to XLA have 
been found in all five domains of the Btk kinase, i.e. PH, TH, SH3, SH2 and the 
catalytic kinase domain (Hansson et al., 1998). 
Src family kinases are relatively well-studied non-receptor tyrosine kinases (Fig. 
2 
1). Intramolecular interactions between the phosphorylated tail and the SH2 domain 
of Src, and between the SH2-kinase domain linker and the SH3 domain, stabilize an 
inhibitory conformation, which holds the Src kinases in the inactive state. Tec family 
kinases share structural homology with the Src family tyrosine kinases, except for the 
presence of the N-terminal domains and the absence of the C-terminal negatively 
regulatory tail in the Tec kinases, indicating that the regulatory mechanism of the Tec 
and Src family kinases may differ from each other (Fig. 1). Unlike the Src kinases, the 
mechanism by which Tec family kinases are regulated is not well understood.  
 
 
Fig.1 Domain structure of Src kinase and Tec family kinases. From the N-terminal to the 
C-terminal, Src family kinases contain a unique domain, a Src-homology 3 (SH3) domain, a 
Src-homology 2 (SH2) domain, a kinase domain and regulatory tail. Tec family kinases except Rlk 
contain a pleckstrin homology (PH) domain, a Btk homology (BH) domain or a proline-rich region 
(PR), an SH3 domain, an SH2 domain and a kinase domain. Rlk has a palmitoylated cysteine 




Domain structure of Itk 
Itk contains five domains. The N-terminal domain is a PH domain, which binds 
PtdIns(1,4,5)P3 (PIP3), the products of phosphatidyl inositol 3 Kinase (PI3K). The PH 
domain is followed by a Tec homology (TH) domain that includes a BH domain and a 
proline-rich region (PR). The Btk motif binds Zn2+ and stabilizes the PH domain. Like 
all of the other Tec family kinases, Itk has an SH3 domain and an SH2 domain, which 
can bind to PRs and phosphotyrosine sequences, respectively. All of the domains 
described above participate in the regulation and localization of the kinase. The very 
C-terminal domain is a catalytic kinase domain (KD), composed of a small N-terminal 
lobe and a large C-terminal lobe, a general fold that is the same as the kinase 
domains of other tyrosine kinases (Huse and Kuriyan, 2002).  
The non-catalytic domains of Itk regulate the function of the kinase by mediating 
different protein-protein and protein-ligand interactions. The Itk PH domain not only 
mediates the membrane localization by binding to PIP3 as mentioned above, but also 
binds to lipid ligand inositol(1,3,4,5)-tetrakisphosphate (IP4), as described by Sauer et 
al. (Huang et al., 2007). The PH-IP4 binding was believed to enhance the PH-PIP3 
interaction. Therefore Itk can be regulated by PI3K and ItpkB (IP3 3-kinase B), which 
generate PIP3 and IP4, respectively. The Itk PH domain is also known to interact with 
activated TCR-CD3 complex (Perez-Villar et al., 2001). Some mutations in the Btk 
4 
PH domain, which is highly homologous to Itk, were shown responsible for the XLA 
disease (Hyvonen and Saraste, 1997; Baraldi et al., 1999).  
The proline-rich region (PR) of Itk is critical for Itk activation, because it is needed 
for Itk binding to Lck, which is essential in Itk activation (Hao and August, 2002). The 
Itk SH3 domain binds to its own PR inside the Itk TH domain in an intramolecular 
manner (Andreotti et al., 1997). In addition, the SH3 domain can interact with Itk SH2 
domain in a non-canonical way, which results in the oligomerization of Itk which might 
reduce kinase activity (Brazin et al., 2000). In addition to the interaction with itself, it is 
also known that the Itk SH3 domain interacts with many different proteins, including 
Wiscott-Aldrich Syndrome protein (WASp), hnRNP-K, Fyn, c-Cbl, Sam68, CD28 and 
karyopherin (Rch1α) (Perez-Villar et al., 2001). 
The SH2 domain is shared in many signaling proteins and is well-known for its 
binding to phosphotyrosine-containing sequences. As already described for the SH3 
domain above, the Itk SH2 domain interacts with the Itk SH3 domain in an 
non-classical manner. The Asn286-Pro287 peptide bond in Itk SH2 domain 
undergoes an interconversion between cis and trans conformation in solution (Brazin 
et al., 2002). The cis conformation favors the Itk SH3/SH2 interaction, while trans 
favors the classical SH2-phosphotyrosine (of SLP76) binding (Breheny et al., 2003; 
Pletneva et al., 2006). The SH2 domain was also reported to bind to PI3-K and PLC-γ 
1 through canonical interactions. The Itk SH2 domain has also been found to serve 
5 
as a necessary substrate docking module when the kinase auto-phosphorylates itself 
on Y180 within SH3 domain after membrane translocation and phosphorylation on 
the activation loop (Joseph et al., 2007). 
 
The function of Itk in T cells 
Itk is expressed in T-lymphocytes, and is involved in T-cell receptor (TCR) 
downstream signaling. Itk is activated upon ligation of the TCR and CD2 and CD28 
receptors. It phosphorylates the tyrosine at position 783 of phospholipase C-γ 1 
(PLC-γ 1, the natural substrate of Itk) and thereby activates this lipase in vivo. The 
activated PLC-γ 1 hydrolyzes PtdIns(4,5)P2 and the product, Ins(1,4,5)P3, triggers the 
subsequent Ca2+ mobilization (Shan and Wange, 1999; Bunnell et al., 2000) (See Fig. 
2). Mice that don’t express Itk have reduced cytokine production and proliferation 
following T cell receptor crosslinking (Liao and Littman, 1995; Gibson et al., 1996; 
Schaeffer et al., 1999). Moreover, selective inhibition of Itk blocks T cell activation 
and murine inflammation (Lin et al., 2004). All these results suggest that Itk plays an 
important role in T cell development and function. Itk might therefore be an ideal 
therapeutic target for immunosuppressive and inflammatory diseases. 
Figure 2 shows the TCR signaling pathway (Finkelstein and Schwartzberg, 2004). 
A complex is formed by LAT (linker for activation of T cells), GADS and SLP76 
(Src-homology-2-domain-containing leukocyte protein of 76 kDa), creating a platform 
6 
for recruitment of multiple signaling molecules, including Itk, VAV1, RAC, CDC42 
(cell-division cycle 42), WASp (Wiskott-Aldrich Syndrome protein), ARP2 
(actin-related protein 2 homologue) and ARP3. Itk binds onto this complex and 
becomes fully activated.  
Full activation of Itk by TCR engagement requires three steps: membrane 
localization, trans-phosphorylation by Lck and auto-phosphorylation, (Lucas et al., 
2003; Finkelstein and Schwartzberg, 2004). i) The Itk PH domain binds to 
PtdIns(3,4,5)P3 (PIP3), which translocates the kinase onto the membrane and brings 
it in proximity to some membrane-associated proteins and other signaling molecules. 
ii) Upon recruitment of Itk to the membrane, Lck phosphorylates a conserved Y511 at 
the activation loop of the Itk kinase domain. In Itk deficient primary T cells, a mutant 
(Itk Y511F) completely fails to restore Itk mediated signaling (Wilcox HM and Berg LJ, 
2003). iii) Finally Itk auto-phosphorylates Y180 in the SH3 domain within the same 
molecule. The auto-phosphorylation of Y180 interferes with the SH3 domain ligand 
binding and is believed to have a positive effect on cytokine production and ERK 
activation (Wilcox and Berg, 2003).  
PLC-γ 1 is then activated by phosphorylation by Itk and this leads to the 
generation of inositol 1,4,5-triphosphate (IP3), which is required for Ca2+ flux within 
the cell, and diacylglycerol (DAG), which activates members of protein kinase C 
family and RAS guanyl–relaseing protein (RASGRP). This results in the downstream 
7 
activation of several mitogen-activated protein kinases, such as JNK (JUN 
amino-termical kinase), ERK1 (extracellular-signal-regulated kinase 1), ERK2 and 
some other effectors which direct gene transcription.   
 
Fig.2 T-Cell receptor (TCR) signaling pathway. (Finkelstein and Schwartzberg, 2004) 
 
Recent data have shown that in addition to its role in the regulation of PLC-γ 1, Itk 
is also required for TCR-induced polarization of the actin cytoskeleton (Finkelstein 
and Schwartzberg, 2004; Billadeau and Burkhardt, 2006). The downstream effectors 
of IP3 and DAG (shown above), together with the signaling proteins accumulated on 
the LAT-GADS-SLP76 platform regulate the TCR-mediated T cell polarization, 
8 
adhesion and migration. When TCR is activated, T cells polarize the actin 
cytoskeleton, certain receptors and some signaling molecules, which rearrange later 
at the site of TCR engagement into the immune synapse. Actin polarization is 
required for effective T-cell activation (Cannon and Burkhardt, 2002). Studies have 
shown that mutations affecting proximal TCR signaling molecules that block TCR 
signaling, have defects in actin reorganization.   
 
Cyclophilin and Peptidyl-prolyl Isomerases 
 As mentioned above, the peptide bond between Asn286 and Pro287 can take 
both cis and trans conformation. This cis-trans isomerization prompted early studies 
in the lab that examined whether cyclophilin A (CypA), a member of peptidyl-prolyl 
isomerase (PPIase), interacts with Itk (Brazin et al., 2002). CypA was found to 
decrease Itk and PLC-γ 1 tyrosine phosphorylation levels, but surprisingly CypA does 
not affect cis-trans isomerization in the Itk SH2 domain. In this thesis, I further explore 
the role of CypA in the regulation of Itk functions. 
 
There are three families of PPIases 
The planar peptide bonds in proteins for which structures have been solved are 
predominantly in the trans conformation (Barik, 2006). The peptide bonds previous to 
proline residues can take both cis and trans conformation, so the cis-trans 
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isomerization of the peptide bonds on the N-terminal of prolines is essential for 
proper folding of nascent proteins (Barik, 2006). PPIases are a class of enzymes that 
catalyze this type of interconversion (Lippens et al., 2007). There are three families of 
PPIases: cyclophilin (Cyp), FK506-binding protein (FKBP) and parvulin family. They 
all show the catalytic activity on the cis-trans isomerization of the X-Pro peptide bond, 
where X is one of the 20 amino acids. Interestingly, the three PPIase families are 
unrelated in either sequence or tertiary structure (Barik, 2006). In budding yeast there 
are eight cyclophilin family genes (CPR1–8) and four FKBP genes (FPR1–4); in 
mammals at least five cyclophilins (CypA–D, Cyp40) and six FKBPs (FKBP12, 12.6, 
13, 25, 52, 54) have been identified. In contrast, eukaryotes have one or at most two 
parvulin family PPIases (Hunter, 1998). 
Cyp and FKBP are chaperones involved in the folding of a number of proteins, 
such as collagen (Bachinger, 1987; Davis et al., 1989; Steinmann et al., 1991), 
chymotrypsin inhibitor (Tan et al., 1997), carbonic anhydrase  (Freskgard et al., 
1992; Kern et al., 1995) and ribonuclease (Kiefhaber et al., 1990). The exact catalysis 
mechanism remains unclear, and no evidence has shown that PPIase activity is 
absolutely essential in vivo (Barik, 2006). In some cases, PPIases may participate in 
assembly/disassembly of protein complexes, protein trafficking, and direct regulation 
of protein activity (Hunter, 1998). 
Different PPIase families show different specificity towards substrate recognition. 
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Harrison and Stein tested the specificity for cyclophilin A (CypA) and FKBP12 using 
succinyl-Ala-Xaa-cis Pro-Phe-pNA short peptide, where Xaa is a certain amino acid. 
CypA and FKBP12 are the smallest members in Cyp and FKBP families of PPIases, 
respectively. Piotukh et al. (Piotukh et al., 2005) screened the consensus peptide 
motif (Phe-Gly-Pro-Xaa-Leu-Pro) binding to CypA with high affinity. They found that 
FKBP12 preferred Xaa to be hydrophobic residues, while CypA showed less 
dependence on Xaa. Apart from this result, it has been reported that the substrate 
recognition of PPIases involves interactions with additional residues lying on either 
side of the proline residue and also somewhere else in the protein (Gamble et al., 
1996; Hunter, 1998).  
Cyclosporin (CsA) and FK506 are small, naturally occurring molecules found to 
bind CypA and FKBP specifically. In spite of the lack of sequence and structural 
similarity between Cyp and FKBP, CypA-cyclosporin and FKBP12-FK506 complexes 
can both bind to a composite surface formed by the catalytic and regulatory subunits 
of calcineurin (Ca2+/calmodulin-dependent protein phosphatase 2B, PP2B) and 
inhibit the activity of this phosphatase (Huai et al., 2002). This inhibition results in 
elevated phosphorylation of a number of calcineurin substrates, including NFAT, 
nuclear factor of activated T cells, which causes phospho-NFAT and failure for it to 
translocate to nucleus. This in turn blocks the transcription of TCR-mediated cytokine. 




Cyclophilin family PPIases and cyclophilin A 
Cyclophilins are ubiquitous proteins (Galat, 1999) found in all subcellular 
compartments, which are involved in a wide variety of processes including protein 
trafficking and maturation, receptor complex stabilization, apoptosis, receptor 
signaling RNA processing and spliceosome assembly. All higher organisms possess 
multiple cyclophilin paralogs. For example, humans have at least 16 cyclophilins that 
have a range of molecular weight and intracellular locations (Barik, 2006), while 
Arabidopsis has 14 cyclophilins identified. Some lower eukaryotes contain 
cyclophilins, too. Saccharomyces cerevisiae was found to have eight cyclophilins, all 
of which have counterparts in human. The size of cyclophilin family PPIases ranges 
from 18 KDa to more than 300 KDa. CypA is the prototypical minimal cyclophilin, with 
a molecular weight of 18 KDa, contains only the PPIase domain. Other cyclophilins 
may contain a signaling sequence, which targets them to specific organelles. Human 
CypA resides in both the cytosol and nucleus; CypB is in the endoplasmic reticulum; 
CypC is located in membrane; CypD is in mitochondria and Cyp19 is found in the 
nuclear spliceosome.  
CypA is widely expressed in many species and tissues with the concentrations of 
1-3 μg/mg proteins (Ryffel et al., 1991). CypA contains eight anti-parallel β strands 
12 
that form a right-handed β barrel with an α helix at either end, as shown in Fig. 3. 
Cyclosporin (CsA) binds to the outer surface of CypA instead of the hydrophobic core 
of the β barrel. 
 
Fig. 3 Solution structure of cyclophilin A by NMR (1OCA.pdb) 
 
PPIases participate in some protein regulation 
 Intramolecular interactions within a single polypeptide may provide a common 
regulatory strategy to modulate protein structure and function (Blume-Jensen and 
Hunter, 2001; Pufall and Graves, 2002; Schlessinger, 2003; Reindl and Spiekermann, 
2006). It has been recognized that cis-trans isomerization of Xaa-Pro peptide bonds 
as hinges can be involved in protein regulation (Lu et al., 2007). The cis-trans 
interconversion of the peptide bond previous to Pro8 of the 5-HT3 receptor channel 
protein provides the switch that controls the open and close states of the channel 
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(Lummis et al., 2005). Another example was shown by Eckert and coworkers (Eckert 
et al., 2005). The assembly of N1 and N2 domains in gene-3-protein was limited by 
Gln212-Pro213 peptide bond isomerization. The exchange was very slow according 
to their measurement, about 6200 seconds per isomerization. The switch was turned 
on by converting the peptide bond from the cis to trans conformation. 
There are several examples showing that PPIases are involved in kinase 
regulation. Yu and coworkers (Yu et al., 2006) reported that PIN1 negatively 
regulates Btk signaling pathway by reducing Btk’s half-life in vivo. PIN is a member of 
parvulin PPIase family, specifically binds to pSer-Pro and pThr-Pro motif in substrate 
proteins. The target region exists in the Btk PH domain, and the interphase 
phosphorylation of Ser115 and mitosis phosphorylation of Ser21 are critical for the 
PIN1-Btk cell cycle-dependent interaction. It is also known that CypA binds to the 
viral protein R (VPR) of HIV-1 virus (Zander et al., 2003). The inhibition of CypA or 
CypA knock-out T cells gives reduced VPR expression. Sarkar et al. reported that the 
Crk adaptor protein underwent an intramolecular interaction between its two SH3 
domains and thus autoinhibits itself (Sarkar et al., 2007). The peptide bond of 
Gly237-Pro238 in the linker region between the two SH3 domains serves as a hinge 
and its cis-trans isomerization regulates the SH3 interaction. Interestingly, CypA was 
found able to accelerate this interconversion. 
 There are also cases where enzymes other than protein kinases are regulated by 
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the PPIases. Aspergillus oryzae RNase T1 has two Ser-Pro motifs, cis Ser54-Pro55 
and trans Ser72-Pro73. ERK2 kinase can phosphorylate both Ser residues. However 
this kinase is known to phosphorylate the trans-isomer only. Weiwad et al. found that 
cyclophilin A increased the cis Ser phosphorylation rate, indicating that CypA 
catalyzes the interconversion of the isomerization of the Ser-Pro peptide bond, and 
hence regulates the Ser phosphorylation by ERK2 (Weiwad et al., 2004).  
 
  In our group, Brazin et al. have shown that CypA down-regulates Itk activity in 
vitro and reduces the phosphorylation level of Itk and PLC-γ 1 (Brazin et al., 2002). 
Based on this result, in Chapter 2 of this thesis, I further explored how CypA 
regulated Itk using biochemical and NMR approaches. The structure of both CypA 
and the Itk SH2 domain have been solved by NMR (Ottiger et al., 1997; Pletneva et 
al., 2006), so it is convenient to study the binding of these two proteins by NMR 
titration experiments.  
 
HS1 —— the leukocyte-specific homolog of cortactin 
 T cells undergo dramatic shape changes in response to interacting with 
antigen-presenting cells (APCs), to form immune synapse. The reorganization of 
actin cytoskeleton in T cells is a very important process for signaling, differentiation, 
migration through tissues and execution of effector functions. Many proteins have 
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been shown to be involved in actin regulation, including cofilin, myosin II, ezrin, 
moesin, Wiskott-Aldrich Syndrome protein (WASp), WAVE2 and HS1 (Schuuring et 
al., 1998; Brunati et al., 2005; Huang and Burkhardt, 2007; Muzio et al., 2007; 
Burkhardt et al., 2008). And as already mentioned in the first part of this chapter, Itk 
plays a role in this process, too (Billadeau and Burkhardt, 2006; Burkhardt et al., 
2008). 
The hematopoietic lineage cell-specific protein, HS1, also called HCLS1 or 
LckBP1, is the leukocyte specific homolog of cortactin, expressed only in 
hematopoietic and lymphoid cells (Brunati et al., 1999; van Rossum et al., 2005). 
Cortactin is a widely expressed oncogene identified as an actin regulatory protein 
(Daly, 2004). The HS1 protein contains an Arp2/3 complex binding domain, followed 
by a sequence of 37 amino acid tandem repeats and a coil-coiled region, which bind 
F-actin (Hao et al., 2005; Gomez et al., 2006), a region that contains several 
proline-rich regions and a C-terminal SH3 domain (Fig. 4). Although the role of HS1 in 
T cell signaling has not been tested, there are in vitro experiments showing that 
cortactin and its homolog HS1 can both activate Arp2/3-dependent actin 
polymerization and therefore prolong the half-life of branched actin structures 
(Weaver et al., 2001; Uruno et al., 2003). However the main function of HS1 protein 
has been thought to be promoting net actin polymerization by bridging between 
Arp2/3 complex and actin filaments. Immunoreceptor-induced proliferation and 
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immunoreceptor-induced apoptosis of T cells are impaired in HS1-deficient mice, 
though they do not exhibit major defects in lymphocyte development.  
 
 
Fig. 4. Domain structure of HS1 protein 
 
 Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism 
that controls its ability to activate N-WASP (Schuuring et al., 1998; Martinez-Quiles et 
al., 2004). Not surprisingly, tyrosine phosphorylation plays an important role in the 
regulation of HS1 function. Burkhardt and coworkers (Gomez et al., 2006) found that 
HS1-deficient T cells had intact TCR activation events, but Ca2+ influx and 
interleukin-2 (IL-2) gene transcription were defective. Also these deficient T cells 
failed to accumulate F-actin at the immune synapse. Similar results have been 
obtained in natural killer cells. Butler et al. (Butler et al., 2008) observed defective 
lysis of target cells, cell adhesion, chemotaxis and actin assembly at the lytic synapse 
by using HS1-knockdown natural killer cells. Two distinct tyrosine residues (Y378 and 
Y397) in the proline-rich region of HS1 were shown to be crucial. Phosphorylation of 
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Y378 is required for chemotaxis and that of Y397 is crucial for integrin signaling and 
recruitment of integrins, adaptors and actin to the lytic synapse.  
HS1 is also known implicated in Systemic Lupus Erythematosus (SLE), a 
prototypic systemic autoimmune disease characterized by the presence of a variety 
of autoantibodies. A polymorphic allele in humans encoding an abnormal form of the 
HS1 protein has been identified in patients having SLE (Sawabe et al., 2003; Otsuka 
et al., 2004). The HS1 protein has six Glu-Pro repeats (from E363 to P374) located 
between the PR and SH3 domain (See Fig. 4). Interestingly the HS1 found in SLE 
patients contains two extra Glu-Pro repeats in this region.  
 Cellular and biochemical work has been done to explore the function of HS1, 
however there has been no study of HS1 at the structural level. The solution NMR 
structure of the HS1 homologue cortactin SH3 domain has been solved (PDB 1x69). 
In Chapter 3 of this thesis, we showed the model of the regulation of HS1 by SH3/PR 
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 CHAPTER 2. Regulation of Itk by Cyclophilin A 
 
ABSTRACT 
 Inducible T-cell tyrosine kinase (Itk) is a Tec family non-receptor tyrosine kinase, 
which plays a central role in the amplification of the signal induced by TCR 
engagement. Itk phosphorylates both Y180 within its own SH3 domain and Y783 of 
phospholipase C-γ 1 (PLC-γ 1) in vivo. The Itk auto-phosphorylation of Y180 
interferes with the Itk ligand binding and has a positive effect on Itk activation. It was 
reported that Itk was regulated by cyclophilin A (CypA), a peptityl-prolyl isomerase 
(PPIase). CypA-/- T helper type II cells from mice showed increased level of 
interleukin-4 and were hypersensitive to T cell receptor stimulation. We demonstrate 
that CypA inhibits Itk Tyr 180 phosphorylation, which is required for the full activation 
of the kinase. This regulation is independent of the PPIase activity. CypA has been 
found to undergo an interaction with kinase domain and SH2 domain of Itk. The CypA 
binding surface on the Itk SH2 domain is localized to a hydrophobic helix and a loop 
region preceeding this helix (V311 to N325); while the binding interface on CypA with 
Itk SH2 was on one side of the protein close to its active site. 
 
INTRODUCTION 
 Inducible T-cell tyrosine kinase, Itk, is an important member of the Tec family 
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tyrosine kinases, the second largest non-receptor tyrosine kinase family, which is 
among the key regulators in the T-cell receptor (TCR) downstream signaling pathway 
(Lucas et al., 2003). Activated Itk phosphorylates the Tyr 783 on phospholipase C-γ 1 
and activates it in vivo. Then PLC-γ 1 hydrolyzes PtdIns(4,5)P2 (PIP2) and the 
product Ins(1,4,5)P3 (IP3) results in the subsequent Ca2+ mobilization (Shan and 
Wange, 1999; Bunnell et al., 2000). The knockout of Itk in mice led to reduced 
cytokine production and proliferation following T cell receptor crosslinking (Liao and 
Littman, 1995; Gibson et al., 1996; Schaeffer et al., 1999). In addition to its role in the 
regulation of PLC-γ 1 and Ca2+ mobilization, Itk is also required for TCR-induced 
polarization of the actin cytoskeleton (Finkelstein and Schwartzberg, 2004). When 
TCR is activated, some signaling proteins including Itk accumulate on the 
LAT-GADS-SLP76 platform and regulate the TCR-mediated T cell polarization, 
adhesion and migration, followed by the rearrangement of some receptors and 
signaling molecules at the site of TCR engagement into the immune synapse.  
There are two well known tyrosine phosphorylation sites in Itk, Y511 and Y180. 
The Src family tyrosine kinase, Lck, phosphorylates Y511 of Itk and partially activates 
Itk, followed by the autophosphorylation of Itk on Y180, which finishes its full 
activation (Lucas et al., 2003; Finkelstein and Schwartzberg, 2004). Brazin et al. in 
our group have shown that CypA down-regulates Itk activity (Brazin et al., 2002). The 
authors reported that CypA, a peptidyl-prolyl isomerase (PPIase), decreased the total 
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tyrosine phosphorylation level of Itk and PLC-γ 1 in an in vitro kinase assay. The 
treatment of Jurkat T cells with CsA (the inhibitor of CypA) increased the 
phosphotyrosine level of both Itk and PLC-γ 1. Additionally, endogenous CypA was 
detected in Itk immunoprecipitates prepared from Jurkat T cells. Luban et al. then 
found that CypA-/- T helper type II cells from mice had increased level of interleukin-4 
and were hypersensitive to T cell receptor stimulation, a phenotype consistent with 
enhanced Itk activity (Colgan et al., 2004). The results of Brazin et al. and Luban et al. 
both support the hypothesis that CypA down-regulates Itk activity in the T cell 
signaling pathway.  
The precise mechanism of Itk regulation by CypA remains unclear, and there are 
several experimental limitations on Brazin’s kinase assays that can be improved. (i) 
The authors used crude Itk prepared from Jurkat T cells, instead of pure enzyme in 
the kinase assays. (ii) In Brazin’s experiment, Itk was used as both the enzyme and 
the substrate for its autophosphorylation. This could be a problem because Itk 
phosphorylation affects its kinase activity. (iii) The authors did not have a specific 
antibody to detect Itk autophosphorylation (at Y180) and transphosphorylation (at 
Y511), but instead used a generic phosphotyrosine antibody. (iv) Finally, Brazin et al. 
did not use a quantitative kinase assay to measure the Itk protein substrate 
phosphorylation levels. Therefore here we further explored the role of CypA in the Itk 
regulation with improved methods. 
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PPIases are a class of enzymes that catalyze the interconversion of cis and trans 
conformation the peptide bond previous to a proline (Lippens et al., 2007). There are 
three families of PPIases, Cyclophilin (Cyp), FKBP and parvulins (Barik, 2006). 
PPIases are chaperones involved in the folding of a number of proteins, such as 
collagen (Bachinger, 1987; Davis et al., 1989; Steinmann et al., 1991), chymotrypsin 
inhibitor (Tan et al., 1997), carbonic anhydrase (Freskgard et al., 1992; Kern et al., 
1995) and ribonuclease (Kiefhaber et al., 1990). They catalyze the conformational 
change of the prolyl peptide bond, the rate-limiting step in the whole process (Lang et 
al., 1987). CypA is the prototypical minimal cyclophilin, with a molecular weight of 18 
KDa. It is well known that cyclosporin A (CsA) forms a complex specifically with CypA 
and inhibits calcineurin, which in turn suppresses T cell activation (Huai et al., 2002). 
CypA is a ubiquitous protein found in many species and tissues with the 
concentrations as high as 1-3 μg/mg proteins (Ryffel et al., 1991).  
We report that CypA may regulate Itk activity by interacting with kinase domain 
and SH2 domain of Itk. The auto-phosphorylation level of Itk tyrosine 180 was 
decreased in presence of CypA. This regulation is not dependent on CypA activity. By 





Cyclophilin A has no effect on the phosphorylation of a peptide substrate by Itk 
To test whether CypA affected Itk activity directly, we first did an in vitro kinase 
assay to quantify the CypA effect on Itk kinase activity using an artificial biotin-labeled 
peptide (EQEDEPEGIYGVLF, named peptide B) as the phosphate acceptor. The 
peptide B mimics the peptide sequence of some tyrosine kinase substrates, and was 
found to be phosphorylated by Itk in vitro (Hawkins and Marcy, 2001; Joseph et al., 
2007). The experiments were done using two different Itk concentrations, 100 nM and 
600 nM. The CypA concentration ranged from 0 to 60 μM. Unexpectedly, CypA 
showed no effect on the phosphorylation of the tyrosine in peptide B at all levels of Itk 
and CypA, as shown in Fig. 1. We interpret this result by concluding that CypA 
doesn’t affect Itk peptide substrate phosphorylation. This suggests that CypA 
down-regulates Itk not simply by blocking the active site of the kinase or by simply 
decreasing the kinase catalytic activity.  
 
Cyclophilin A reduces phosphorylation of Itk SH3-SH2 Tyr 180 
Joseph RE et al. observed a direct interaction between Itk kinase domain and Itk 
SH2 domain by means of a pull-down assay as well as a competitive functional 
kinase assay (Joseph et al., 2007). The Itk SH3-SH2 truncated construct can be 
phosphorylated by Itk on Tyr 180 within the SH3 domain. Itk SH2 domain binds to its 
kinase domain in a way that serves as a docking motif for the adjacent SH3 domain in 
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autophosphorylation, and Itk KD is the minimal domain required for substrate docking. 
Adding the isolated SH2 domain of Itk gave reduced Tyr 180 phosphorylation level on 
Itk SH3-SH2 truncated construct but had no effect on the phosphorylation of the small 
“peptide B” substrate, similar to our CypA result shown above. In the light of this fact, 
we hypothesize that CypA may interact with Itk in a way that blocks the substrate 
docking by SH2 domain, as shown in Fig. 2. 
If the hypothesis described in Fig. 2 is correct, then CypA would then reduce the 
phosphorylation of the SH3-SH2 protein substrate but not the phosphorylation of the 
artificial peptide B substrate. Accordingly, we tested this idea by using the protein 
substrate of Itk, the truncated construct containing Y180 (Itk SH3-SH2). Adding CypA 
to the in vitro kinase functional assay reduces the Tyr180 phosphorylation level of the 
Itk SH3-SH2 substrate, as Fig. 3 shows. In the western blot in Fig. 3a, we used an 
antibody (anti-BtkpY223) that recognizes both pY223 of Btk and pY180 of Itk. In the 
first three lanes in Fig. 3b, a quantitative kinase assay was done in a similar way to 
the assay shown in Fig. 1. The phosphorylation of Y180 in SH3-SH2 was inhibited at 
a 10 μM and 25 μM of CypA. CypA affects its protein substrate phosphorylation but 
not the peptide substrate phosphorylation, indicating that CypA might regulate Itk by 
blocking access to substrate rather than by directly inhibiting the enzymatic activity.  
Since CypA is a member of a peptidyl-prolyl isomerase family, we were intrigued 
to know if there was any proline isomerization happening during this regulation 
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process. Interestingly neither of the two active site mutants of CypA, CypA (R55A) 
and CypA (H126Q) showed significant restoration of the phosphorylation of Tyr180 of 
Itk SH3-SH2, compared with wt-CypA (Fig. 3b). In agreement with this result, 
pre-mixing of CypA with cyclosporin A (CsA) also did not affect Tyr180 
phosphorylation compared to CypA alone, as shown in Fig. 3d. These results 
suggested that the active site of CypA was not involved in the regulation of Itk 
autophosphorylation on Y180. Fig. 3c ruled out the possibility that the 
phosphorylation decrease was caused by buffer condition changes for the kinase 
reactions. No significant loss of phosphorylation of Y180 was detected for the buffer 
controls. Note that all the kinase assays were treated with 1 mg/ml BSA except that 
the BSA control samples in Fig. 3c had an extra 10 or 25 μM of BSA. BSA increases 
the kinase stability and this accounts for the increase in phosphorylation observed in 
the BSA controls. Also notice that there are differences between the assays, as seen 
in the different initial reaction rates in the “blank” in Fig. 3b and 3c. These differences 
could be caused by the different preparations of Itk used in the assays. We have 
found that the Itk activity from different batches differs and affects reproducibility 
between assays. In Fig. 3d, the negative controls (lysozyme and the Grb2-SH2 
domain) gave a bit less phosphorylation of SH3-SH2 in 25 μM than in 10 μM, though 
the decrease is less than the cases where CypA was added. Nevertheless the errors 
between samples in the same assay are relatively much smaller, and the tendency of 
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the CypA’s effect on SH3-SH2 phosphorylation is consistent. 
 
Cyclophilin A interacts with Itk kinase domain directly 
CypA may regulate Itk by either a direct or indirect interaction. To address this, 
we tried to pull down CypA or FKBP, using Itk kinase domain (KD) or Itk SH2-KD 
truncated construct (2KD) immobilized on anti-FLAG beads. FKBP was used as a 
control for CypA in this assay. As Fig. 4 shows, CypA was detected in this pull-down 
assay at a concentration of 10 μM, the same concentration that showed an effect on 
pY180 level of Itk dual domain in the kinase assay (Fig. 3). This indicates that CypA 
binds to Itk directly, and the kinase domain of Itk is the minimal necessary motif that 
interacts with CypA. Unexpectedly, while FKBP also decreased Itk dual domain 
Tyr180 phosphorylation level to the similar degree to CypA (Fig. 3a), it was not pulled 
down by either Itk KD or 2KD fragments. The reason for the effect on Itk activity is not 
known at this time. However the decrease of Itk Y180 phosphorylation is a specific 
one since Grb2 SH2 domain and lysozyme could serve as negative controls in the 
kinase assay (Fig. 3d) 
When Joseph RE and co-workers mapped out the Itk kinase domain docking 
surface on the Itk SH2 domain, they found that the interface consists of a patch with 
basic residues (Joseph RE et al. unpublished data). Based on this knowledge and 
our data showing that like the SH2 domain, CypA interacts with the Itk kinase domain, 
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we considered that CypA might interact with Itk kinase domain in a similar way and 
therefore targeted basic side chains in CypA. We made a set of CypA mutants and 
checked if these mutations could restore pY180 of Itk SH3-SH2. The following 
strategies were used when designing the mutants : i) The CypA sequences from 
human, mouse, Arabidopsis and yeast were aligned, and only the amino acids 
conserved in human and mouse were of interest, because they lack Tec family 
tyrosine kinases. ii) Only surface residues, and not core residues that on mutation 
could lead to misfolding, were targeted. iii) Charged, especially basic residues, had 
first priority. By this we generated 18 CypA mutants as shown in Fig. 5a. Similar 
qualitative functional kinase assays were performed with these CypA mutants (as 
those in Fig. 3a), and comparisons were done with wt-CypA. As Fig. 5b shows, none 
of these mutants restored pY180 of Itk SH3-SH2 significantly. Whether this indicates 
that none of these sites are involved in mediating the Itk/CypA interaction or whether 
these mutations need to be combined to disrupt binding has yet to be determined. 
Direct binding assays between the Itk kinase domain and this panel of CypA mutants 
has also not yet been done. 
 
Cyclophilin A has no effect on the Itk Y511 phosphorylation 
 Phosphorylation of Tyr 511 in the Itk activation loop by Src family kinase Lck is 
critical for Itk activation. Brazin et al.’s observation of decreased phosphorylation 
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level of Itk and PLC-γ1 could be caused by less active Itk due to less Y511 
phosphorylation. We therefore did another in vitro kinase assay to examine whether 
CypA has any effect on phosphorylation of Y511 (Fig. 6). We tested 25 and 50 μM 
CypA and neither of these concentrations of CypA gave rise to significant decrease of 
pY511 level, ruling out the possibility that less Y511 phosphorylation led to less active 
Itk and therefore less autophosphorylation in Brazin’s result.  
As described above, apart from the auto-phosphorylation on Y180 of itself, Itk 
also phosphorylates Y783 in PLC-γ1. In order to explore the regulation role of CypA 
on PLC-γ1 (Brazin et al., 2002), Min L in our group tested the effect of CypA on the 
full-length PLC-γ1 phosphorylation on Y783. CypA has been found to decrease the 
phosphorylation level of PLC-γ1 Y783 (Min L, unpublished data). Note that the PLC-γ
1 C-terminal SH2 domain is also a docking motif for its Y783 phosphorylation by Itk in 
a similar way to the Itk SH2 domain docking mechanism (Joseph et al., 2007). 
Therefore both Min’s unpublished results and our results here support our hypothesis 
of the blocking of Itk substrate docking (Fig. 2). 
 
Cyclophilin A shows an interaction with the Itk SH2 domain 
 We have shown that CypA binds to Itk kinase domain. Based on our emerging 
models of what full length Itk looks like, it is possible that Itk SH2 domain, the 
neighboring domain of the kinase domain, also shares interaction with CypA during 
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the regulation. The structure of both CypA and Itk SH2 has been solved by NMR 
(Ottiger et al., 1997; Mallis et al., 2002; Pletneva et al., 2006), so it is convenient to 
study the binding of these two proteins by NMR titration experiments. 
 Here we expressed the Itk SH2 domain or CypA (only one at a time) in 
15N-labeled media, and titrated the labeled protein with the other that is unlabeled. 
The HSQC spectra were collected and overlaid. The NMR chemical shift is sensitive 
and will change if the local chemical environment of a residue is altered by ligand 
binding or conformational changes. Obvious chemical shift perturbation was 
observed when labeled Itk SH2 domain (0.3 mM) was titrated with 0.9 mM of 
unlabeled CypA as shown in Fig. 7a. This suggests that there exists an interaction 
between Itk SH2 domain and CypA in solution. The interaction is a specific one 
because (i) no shift was seen when SH2 domain was titrated with FKBP at even 
higher concentration (1.2 mM, shown in Cyan in Fig. 7a), and (ii) some peaks did not 
shift after titrating with CypA, e.g. R303 (Fig. 7a).  
In a similar way, Itk SH2 domain was also titrated with the two active site mutants 
of CypA, CypA (R55A) and CypA (H126Q), shown in green and blue, respectively in 
Fig. 7a. No different pattern of shift was seen when the titration experiment was done 
using wt-CypA or either of the mutants. The peptide bond previous to Pro 287 of Itk 
SH2 domain takes both cis and trans conformation, and this was believed able to 
regulate the binding between Itk and different proteins. However our experiments 
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indicated that this pivotal proline does not mediate the interaction with CypA, since 
similar extent of shift was obtained when we titrated Itk SH2 (P287A) with CypA (data 
not shown). All of these data are consistent with the kinase assay results above (Fig. 
3), supporting that CypA active site did not play a role in regulating Itk.  
 Fig. 7b shows the reverse titration of labeled CypA (0.26 mM) by the unlabeled Itk 
SH2 domain, and chemical shift perturbation was observed when the Itk SH2 domain 
concentration reached 1.2 mM. The affinity of the binding obtained by this titration 
experiment is of the same magnitude as that got from the titration in Fig. 7a. 
 By overlaying the spectra before and after the addition of ligand, the interaction 
surface was mapped out on both sides (Fig. 8a). Interestingly, most shifted residues 
of Itk SH2 domain were focused on a helix and a loop region before this helix (V311 
to N325, shown in red color, Fig. 8a), which supports that the interaction we are 
looking at is likely to be a specific one. The binding surface on the side of CypA is 
shown in Fig. 8b. Unlike the patch on Itk SH2 domain, the binding surface on CypA 
(shown in red color, Fig. 8b) does not focus within a small patch but consists of one 
side of the protein. This surface is in the outer area of the active site, but the active 





There are examples showing that CypA is involved in kinase regulation. CypA 
binds to the viral protein R (VPR) of HIV-1 virus. Inhibition of CypA or CypA knock-out 
T cells gives reduced VPR expression (Zander et al., 2003). Sarkar et al. reported 
that the peptide bond of Gly237-Pro238 of the Crk adaptor underwent a cis-trans 
isomerization and hence switched between auto-inhibited and active forms. CypA 
was found able to accelerate this interconversion (Sarkar et al., 2007). In some cases, 
PPIases participate in protein interaction without showing isomerase activity, and 
may be involved in assembly/disassembly of protein complexes, protein trafficking, 
and direct regulation of protein activity (Barik, 2006).  
Our results indicated that CypA interacted with Itk kinase domain and SH2 
domain and inhibited the autophosphorylation of the kinase, which is required for the 
full activation of Itk. The CypA-kinase domain interaction is relatively stronger 
compared to the CypA-SH2 one. Due to the difficulty of dealing with Itk kinase 
domain by NMR, we haven’t yet mapped the binding surface of CypA and KD. 
Joseph et al. characterized the SH2/KD interaction and found a basic patch on the 
SH2 side (Joseph et al., 2007). We tried to mutate basic surface residues in CypA but 
none of these recovered Y180 phosphorylation.  
Apart from its direct interaction with Itk kinase domain, CypA binds to Itk SH2 
domain through a weaker interaction. Transient protein-protein interactions have key 
regulatory functions in many physiological processes in the cell cycle (Rudolph, 
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2007). CypA has been found to exist in high concentrations ubiquitously (Ryffel et al., 
1991), so high levels of CypA may ensure enough CypA-protein bindings, especially 
in the case of Itk regulation.  
The interaction surface residues on both Itk SH2 domain and CypA are very 
hydrophobic with several non-polar amino acids containing aromatic rings and 
hydrocarbon side chains (Fig. 8). There is no charged residue involved in the binding 
on the side of SH2 domain. Notice that this hydrophobic patch is far from the pivot 
Pro 287 residue (shown in cyan color, Fig. 8a), which also agrees with our hypothesis 
that CypA does not catalyze the peptidyl-prolyl peptide bond isomerization in this 
case.  
Like the binding patch in Itk SH2 domain, the shifted residues of CypA are also 
hydrophobic except Glu 120 (Fig. 8b). However the Glu 120 negative charged side 
chain is facing towards the opposite side, implying that the chemical shift perturbation 
of Glu 120 is probably caused by slight structural change around it, but not by direct 
interaction with Itk SH2 domain. Also note that most of residues on this surface are in 
loop region, so it is quite likely that they can move towards the ligand by the induction 
upon binding. 
More work is needed to map out the binding residues responsible for CypA/KD 
interaction and to pursue how CypA is affecting Y180 phosphorylation. With this 
knowledge the mechanism of Itk regulation by CypA will be better understood. 
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Targeting the CypA/KD interaction and the transient CypA-SH2 interaction provides 
promising therapies for Itk regulation disorder. 
 
MATERIALS AND METHODS 
Baculoviral and Bacterial Constructs Full-length Itk and truncated Itk constructs 
kinase domain (KD) and SH2-KD were PCR amplified using a reverse primer that 
encoded a FLAG epitope tag. The PCR products were cloned into the 
pENTR/D-TOPO vector (Invitrogen) by TOPO cloning. All of the Itk fragments that do 
not contain KD and CypA (wt and mutants), FKBP and Grb2SH2 were cloned in 
pGEX-4T vector for production and purification from bacteria as described previously 
(Brazin et al., 2000). The Itk SH3SH2 dual domain fragment used for radioactive 
kinase assay was created by PCR and included an N-terminal biotinylation sequence. 
For the SH3SH2 dual domain, we introduced two point mutants (W208A and I282A) 
to eliminate complications that may arise from dimerization of the substrate (Brazin et 
al., 2000). The phosphorylation level for wt-dual domain and the one with two point 
mutations is same. The biotinylated protein was purified by affinity purification using 
an avidin resin (Pierce). All mutations were made using the site-directed mutagenesis 
kit (Stratagene). All constructs were verified by sequencing at the Iowa State 
University DNA Synthesis and Sequencing Facility. 
Baculovirus Production. The pENTR vectors with various inserts were 
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recombined in vitro with BaculoDirect C-Term Linear DNA (Invitrogen) using the LR 
Clonase II enzyme (Invitrogen). The DNA was then transfected into Sf9 cells using 
Effectene (Qiagen). Three rounds of viral selection and amplifications were carried 
out. The Sf9 cells were infected with a 1:1 Itk:Lck baculovirus ratio for protein 
production. The cells were harvested 72 hours postinfection, rinsed once with PBS 
buffer, and stored at -80 oC. Following purification, the Itk enzyme construct was 
assessed for Tyr 511 phosphorylation using a Btk pY511 specific antibody, which 
ensured that coexpression with Lck produced appropriately activated Itk (Wilcox and 
Berg, 2003).  
Pull-Down Assays. The Itk kinase domain (ItkKD) truncated construct includes 
residues from Trp 355 to the C-terminal, and the Itk SH2-KD (2KD) construct starts 
from Ser 190. Both constructs are FLAG-tagged. The purified 0.5 μM FLAG-tagged 
ItkKD) and 2KD immobilized on an anti-FLAG resin were incubated with 10 μM 
purified CypA or FKBP (negative control) in RIPA buffer [50 mM Tris (pH 7.4), 150 
mM NaCl, 1 mM PMSF, 1% NP40, 1 mM EDTA and 1mM NaF] at 4 oC overnight. The 
sample were washed, boiled, resolved on a SDS-PAGE gel, transferred to a PVDF 
membrane and Western-blotted with an anti-CypA (Santa Cruz) or anti-FKBP 
antibody (Santa Cruz).  
Protein Purification. Baculovirus-produced proteins were purified as previously 
shown (Hawkins and Marcy, 2001). Cell pellets were resuspended in lysis buffer [50 
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mM Tris (pH 8.0), 500 mM NaCl, 2 mM EDTA and 1 mM PMSF] and lysed by dounce 
homogenization. The homogenate was centrifuged at 16K rpm for 1 hour at 4 oC. 
Glycerol was added to the supernatant to a final volume of 10%, and then the mixture 
wasincubated with anti-FLAG M2 affinity resin (Sigma) for 5 hours at 4 oC. The resin 
was rinsed five times in wash buffer [50 mM Tris (pH 8.0), 500 mM NaCl, 1 mM 
PMSF and 10% glycerol]. If necessary for kinase assays, the protein was eluted in 
elution buffer ( Wash buffer with 200 μg/mL FLAG peptide) and stored at -80 oC. The 
purified protein was quantified by measuring OD at 280 nm. All proteins were >95% 
pure by Coomassie staining. 
Kinase Assays and Western Blotting. Full-length Itk was incubated with the 
indicated substratesin an in vitro kinase assay buffer [50 mM HEPES (pH 7.0), 10 
mM MgCl2, 1 mM DTT, 1 mg/mL BSA, 1 mM Pefabloc and 200 μM ATP] for 1 hour at 
room temperature. The samples were boiled, separated by SDS-PAGE and 
transferred to a PVDF membrane. The membranes were blotted with an 
anti-BtkpY223 antibody and an anti-BtkpY551 andibody to detect pY180 and pY511, 
respectively in Itk. An anti-Itk antibody was used to detect Itk level. In quantitative 
kinase assays, the peptide B concentration was 0.4 mM. 
NMR Experiments. NMR spectra were recorded at 25 oC on a Bruker AVII 700 
spectrometer equipped with a 5 mm HCN z-gradient cryoprobe operating at 700.133 
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Fig. 1. CypA has no effect on Itk activity. An artificial peptide (peptide B, 0.4 mM) was incubated 
with 100 nM or 600 nM Itk and CypA at various concentrations. The enzymatic reaction was 













Fig. 2. Hypothesized competition mechanism for the regulation of Itk autophosphorylation by 
CypA. The Itk SH2 domain interacts with the Itk kinase domain and serves as a docking motif for 
the SH3 domain phosphorylation. Adding CypA might interact with the Itk kinase domain and thus 












(a)             (b) 
   
 
(c)               (d) 
   
 
Fig. 3. CypA decreases pY180 level of Itk SH3SH2 dual domain. (a) Western blot result done in 
duplicate. 1 μM Itk SH3SH2 domain was incubated with 0, 10 or 25 μM CypA (wt or one of the 
mutants) in HEPES buffer. The reaction was carried out by adding 100 nM Itk at room 
temperature for 1 hour. Western blot was used to detect Y180 phosphorylation level and to 
compare Itk enzyme level. Coomassie stain of the gel showed Itk SH3SH2 and CypA levels. (b) 
Quantative assay result. 1 μM biotinylated Itk SH3SH2 domain was incubated with 10 or 25 μM 
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wt-CypA, CypA (R55A), CypA (H126Q) or FKBP in HEPES buffer. The reaction was carried out 
by adding 100 nM Itk at room temperature for 10 min. “Blank” means there was no addtives 
except the reagents necessary for the kinase assays. “wt” R55A, H126Q and FKBP mean that 
wt-CypA, CypA(R55A), CypA(H126Q) and FKBP were added to the assay, respectively. The 
number following these labels are the concentration (in μM) of each individual additives. (c) 
Buffer control for the assay shown in (b). The reaction conditions are same as in (b) except that 
same amount of buffer for the CypA purification was added to replace CypA samples in buffer-10 
and buffer-25. An extra of 10 and 25 μM BSA were added in BSA-10 and BSA-25, respectively. 
(d) Cyclosporin A (CsA) has no effect on Itk pY180 phosphorylation. 1 μM biotinylated Itk 
SH3SH2 domain was incubated with 10 or 25 μM wt-CypA, lysozyme, Grb2 SH2 domain, 
(CypA+CsA) or (CypA+DMSO) in HEPES buffer. The reaction was carried out by adding 100 nM 
Itk at room temperature for 10 min. In the experiments containing CsA, CsA concentration was 5 
times of that of CypA ; DMSO was negative control for CsA because CsA was dissolved in DMSO. 
“Blank” and “wt” are same as in (b). “Lysozyme” and “Grb2” mean lysozyme and the Grb2 SH2 
domain. “CsA-blank” and “DMSO-blank” mean only CsA or DMSO but no CypA was added. “CsA” 
and “DMSO” mean CsA and DMSO were added to the assays, respectively, together with 10 or 
25 μM CypA. The number 10 or 25 following the labels means 10 or 25 μM addtives or means 





Fig. 4. The kinase domain of Itk can pull down CypA in vitro, but not FKBP. Purified FLAG-tagged 
Itk kinase domain alone or Itk SH2-kinase domain (0.5 μM) was incubated with 10 μM CypA or 
FKBP in RIPA buffer at 4 oC for 1 hour. Anti-CypA, anti-FKBP and anti-FLAG antibodies were 












 (a)                           CypA surface residues target for CypA mutations 
  
P4 F7 D13 E23 
D27 K31 K44 K49 
P58 K82 K91 P105 N106
E134 E143 K151 Q163 L164






Fig. 5. CypA surface residues targeted for mutations to examine the Itk/CypA interaction. (a) The 
surface mutations made in CypA are shown in red. Single, double or triple residues are mutated 
all to alanine in one construct. pdb ID: 1OCA (b) The experiments were done in the same way as 
shown in Fig. 3a. 1 μM Itk SH3SH2 truncated construct was incubated with 0, 1, 5, 10 or 25 μM 
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CypA (wt or one of the mutants) in HEPES buffer. The reaction was carried out by adding 100 nM 
Itk at room temperature for 1 hour. Western blot was used to detect Y180 phosphorylation level of 
SH3SH2 substrate and to compare Itk enzyme level. Coomassie stain of the gel showed Itk 



















Fig. 6. CypA has no effect on pY511 level of FL-Itk. Flag-tagged FL-Itk with no Lck co-expressed 
in Sf9 cells was purified and used in this assay. 100 nM FL-Itk was incubated with 0, 25 or 50 μM 
CypA in HEPES buffer. The reaction was carried out by adding Lck immunoprecipitated from 
anti-Lck antibody at room temperature for 1 hour. 5 μL anti-Lck beads were used as the enzyme 
for the phosphorylation of Y511 of FL-Itk. Western blot was used to detect Y511 phosphorylation 
level and to compare Itk enzyme level. Note that the anti-BtkpY551 antibody was used to detect 
















Fig. 7. Examples of chemical shift perturbations. (a) Overlay of HSQC spectra for the Itk SH2 
domain titration. The concentration of labeled SH2 domain is 0.3 mM. Black: SH2 alone (no 
ligand); red: 0.9 mM CypA added; green: 0.9 mM CypA(R55A) added; Blue: 1.0 mM CypA(H126Q) 
added; Cyan: 1.2 mM FKBP added. (b) Overlay of HSQC spectra for CypA titrated with the Itk 
SH2 domain. The CypA concentration of labeled CypA is 0.26 mM. Black: CypA alone (no ligand); 








Fig. 8. (a) ItkSH2 surface interacting with CypA, mapped out by NMR titration. Red: Itk SH2 
residues shifted by titrating with CypA; Cyan: Pro287 of Itk SH2 (pdb ID: 1LUN). (b) CypA surface 
interacting with Itk SH2 domain, mapped out by NMR titration. Red: CypA residues shifted by 
titrating with Itk SH2; Cyan: Arg55 and His126 (pdb ID: 1OCA). 
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CHAPTER 3. Structural Study for the Regulation of HS1 
Protein by SH3/PR Interaction 
  
ABSTRACT 
 The hematopoietic lineage cell-specific protein HS1 plays an important role in 
cytoskeleton reorganization. It promotes actin polymerization by bridging between 
Arp2/3 complex and actin filaments. The C-terminal of HS1 protein contains a SH3 
domain and multiple proline-rich regions (PR’s), each of which binds to other 
signaling proteins including HS1BP3, Src family tyrosine kinase Lck and possibly 
WASp-interacting protein (WIP) in vivo. We demonstrate by NMR HSQC experiments 
that HS1 SH3 domain interacts with one of its multiple PR’s (P341 to P344), which 
may prevent their binding to other signaling modules to either the SH3 domain, the 
PR or both. The phosphorylation of Tyr 378 and Tyr 397 is known to be crucial for the 
recruitment of HS1 protein into the immune synapse (IS). By sequence alignment 
with cortactin, the homologue of HS1, we surmised the potential phosphorylation site 
Thr 348 in HS1 that corresponds to S405 in cortactin. We designed Y378E, Y397E 
and T348D mutations in a HS1 truncated construct (E336 to C-terminal) and found 
that these phosphorylation mimics broke the SH3/PR binding. Similar results were 
obtained in a Systemic Lupus Erythematosus (SLE) disease mutant containing two 
extra Glu-Pro repeats (starting from E363). These extra (EP) repeats disrupted the 
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SH3/PR interaction in HS1 protein. Our results suggest the SH3/PR binding to be an 
autoinhibition strategy and provide structural basis for the importance of the 
phosphorylation events as well as for the Lupus allele of the abnormal HS1 protein. 
 
INTRODUCTION 
The reorganization of actin cytoskeleton in T lymphocytes is a very important 
process for signaling, differentiation, migration through tissues and execution of 
effector functions (Brunati et al., 2005; Huang and Burkhardt, 2007; Muzio et al., 
2007; Burkhardt et al., 2008). The hematopoietic lineage cell-specific protein HS1, 
the leukocyte-specific homolog of cortactin, has been found to be important in the 
regulation of cytoskeleton (van Rossum et al., 2005; Billadeau and Burkhardt, 2006). 
HS1-deficient mice have been found to show impaired immunoreceptor-induced 
proliferation and apoptosis of T cells. Defective actin responses have been found in 
mouse T cells where HS1 protein is repressed by RNAi (Gomez et al., 2006).  
The HS1 protein contains an N-terminal acidic region (NTA), a sequence of 37 
amino acid tandem helix-turn-helix (HTH) repeats, a coiled-coil region a proline-rich 
region (PR) and an SH3 domain (Hao et al., 2005; Gomez et al., 2006). HS1 PR is 
well known to bind Lck, and HS1 SH3 domain binds to HS1BP3 (Takemoto et al., 
1999). HS1BP3 preferentially associates with the HS1 SH3 domain and 
overexpression of HS1BP3 mutant leads to decreased IL-2 production. The cortactin 
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SH3 domain binds to WASp-interacting protein (WIP), which forms heterodimer with 
WASp and catalyzes actin filament formation (Daly, 2004). It is not clear whether HS1 
SH3 domain also binds to WIP in vivo, but it does so in vitro (Gomez et al., 2006).  
Tyrosine phosphorylation is also critical in the regulation of HS1 function. In 
T-lymphocytes, tyrosine phosphorylation of HS1 happens predominantly on two 
tyrosine residues, Y378 and Y397, both located between the PR and SH3 domain. 
This phosphorylation event, which is done by Src family kinase Lck and Syk family 
kinase ZAP-70, is required for the recruitment of HS1 protein onto the immune 
synapse (Billadeau and Burkhardt, 2006). By tyrosine phosphorylation of HS1, the 
binding sites are believed to be created for some signaling proteins containing SH2 
domain, such as Src family kinases, Vav1 and PLCγ-1 (Gomez et al., 2006). In 
addition, two Erk phosphorylation sites were identified in human cortactin, S405 and 
S418 (Campbell et al., 1999; Martinez-Quiles et al., 2004; Hao et al., 2005). 
Sequence alignment showed that Thr 348 in HS1 corresponded to Ser 405 in 
cortactin. Given the homology HS1 protein and cortactin share, we were interested to 
see whether phosphorylation of T348 in HS1 would regulate the protein function.  
Furthermore, an interesting tandem Glu-Pro dipeptide repeats (from E363 to 
P374) are located in the linker region previous to SH3 domain. A polymorphic allele in 
human encoding an abnormal form of HS1 protein has been identified in patients 
having Systemic Lupus Erythematosus (SLE), a prototypic systemic autoimmune 
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disease characterized by the presence of a variety of autoantibodies (Sawabe et al., 
2003; Otsuka et al., 2004). Instead of having six repeats of Glu-Pro, the mutant HS1 
in these patients had eight, indicating the importance of this sequence.  
Based on the fact that Y378, Y397, T348 and the (EP) repeats are all located in 
the linker region between HS1 SH3 domain and the PR’s, we hypothesized that HS1 
PR and SH3 domain might undergo an canonical interaction with each other (either 
intramolecularly or intermolecularly), and the phosphorylation of the Thr/Tyr and the 
abnormal (EP) repeats would interfere with the SH3/PR binding by some means. 
NMR is an ideal technique for studying domain-domain interaction at the level of 
amino acids, since HS1 SH3 domain and other truncated constructs containing it can 
be labeled with 15N and expressed in bacteria in large scale.  
Here we report that the SH3 domain of HS1 protein interacts with its proline-rich 
region (Pro 342 to Pro 345). The phosphorylation of Y378, Y397 and T348 and the 
extra two Glu-Pro repeats (starting from E363) individually might disrupt this 
interaction, as indicated by NMR chemical shift perturbation using phosphomimics. 
This study demonstrates the importance of the tyrosine and threonine 
phosphorylation events and might account for one of the reasons of SLE disease on 




The SH3 domain of HS1 interacts with its adjacent PR (Pro 342 to Arg 345) 
First, we examined if the SH3 domain of HS1 would interact with any of its PR’s. 
If yes, which PR does it interact with? Notice that there are four PR’s recognized from 
the sequence, which we arbitrarily named as PR1, PR2, PR3 and PR4 from 
C-terminal to N-terminal of the protein, respectively (Fig. 1). PR3 does not follow the 
canonical PXXP pattern, while the other three PR’s do. We designed and named the 
truncated HS1 constructs in the following way: 1) All constructs contain the SH3 
domain; 2) #1, #2 and #3 mean different length of constructs, from short to long, 
containing 1, 2 and all 4 PR’s; 3) “wt” and “dis” in the brackets denote wild-type and 
Lupus disease forms of HS1 constructs, respectively. The constructs were made as 
shown in Fig. 1 and Table 1.  
Overlay of HSQC spectra of isolated SH3 domain, #1(WT), #2(WT) and #3(WT) 
(Fig. 3) showed chemical shift perturbation for part of residues in SH3 domain, 
indicating that the SH3 domain underwent an interaction with its PR’s, which changed 
the chemical environment of some surface residues of the SH3 domain. The 
exchange between the PR-bound and unbound states of SH3 domain is in the fast 
exchange regime, because some peaks for isolated SH3 domain “shifted” to new 
positions, instead of showing doublets (slow exchange scenario) or broadening 
peaks (intermediate exchange scenario). There were extra crosspeaks in the spectra 
of longer truncated constructs compared with that of SH3 domain, and these extra 
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peaks lied in the middle of 1H dimension of the spectra. This suggested that the linker 
sequence before SH3 domain did not take rigid secondary structure but rather exists 
in a flexible loop conformation. The chemical shift perturbation was observed in 
#1(WT) construct, which supported that PR1, the far C-terminal PR, was the minimal 
PR binding to SH3 domain of HS1 protein. To further confirm this finding, we created 
a PR mutant in truncated constructs #1(WT), named #1(WT)-PRM (P342A, P345A 
and R347A in PR1). As expected this mutation disrupted the binding between SH3 
domain and PR1 completely, releasing the SH3 domain back to the free form. 
Therefore we demonstrate that SH3 domain of HS1 protein self-interacts with its 
PR1. 
 
The SH3/PR interaction is an intramolecular one 
In principle, the SH3/PR interaction can be either intramolecular or intermolecular, 
and this can be determined by measuring the line-widths for #1(WT) and the PR 
mutant #1(WT)-PRM. In this situation, line-width broadening could be caused by two 
factors, a) molecular weight increase and b) ligand binding. Larger proteins have a 
slower tumbling rate in solution and broader line-widths for the peaks for all the 
residues of the proteins. Ligand binding to some residues leads to less flexible side 
chains, slower exchange rate and therefore results in line-width broadening only in 
these interface residues. Notice that those residues not involved in the ligand binding 
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do not have broader line-widths, if we leave the molecular weight change factor out of 
account. In the HSQC spectra for both #1(WT) and #1(WT)-PRM, we picked 10 
resonances (in 1H dimension) outside the binding pocket, i.e. 10 peaks without 
significant chemical shift perturbations. If the SH3/PR binding is an intramolecular 
one, no significant line-width broadening should be expected for these resonances, 
because the molecular weight is same for both the bound and unbound constructs. In 
contrast, if the binding is an intermolecular one, there should be some line-width 
difference between #1(WT) and #1(WT)-PRM, because the former is oligomeric but 
the latter is monomeric.  
 The line-width analysis is shown in Table 2. There is almost no line-width 
alteration between the peaks in #1(WT) and #1(WT)-PRM. As a control, the 
line-widths of 5 peaks for residues involved in SH3/PR interaction were also 
measured, and as can be seen in Table 2, the PR-mutant shows smaller line-widths 
due to the lack of binding. This result demonstrates that the SH3/PR interaction in the 
HS1 protein is an intramolecular one and that exchange broadening is occurring for 
residues at the binding interface. 
 
Phosphorylation of Y378, Y397 and T348 disrupts SH3/PR interaction in HS1 
 It has been reported that phosphorylation of Tyr 378 and Tyr 397 of HS1 proteins 
is critical in the regulation of HS1 functions (Gomez et al., 2006; Butler et al., 2008). 
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S405 phosphorylation by ERK in cortactin, which corresponds to T348 in HS1, also 
plays an important role in cortactin regulation (Campbell et al., 1999; Martinez-Quiles 
et al., 2004; Hao et al., 2005). Given the fact that SH3 domain and PR of HS1 are 
binding motifs for other signaling molecules, we hypothesized that the above 
phosphorylation events disrupted the binding between SH3 and PR, making the 
binding sites available for other signaling proteins and thus starting downstream 
signaling events. It is challenging to produce homogeneously phosphorylated protein 
for NMR use, so we designed Y378E and Y397E to mimic the phosphorylated forms 
of tyrosines in truncated HS1 construct #1(WT) as the first step to test the effect of 
phosphorylation of Y378 and Y397 in HS1. In the light of the homology HS1 and 
cortactin share, we also included T348D in this mutation study. Here we mimicked 
phospho-threonine with Asp due to the size difference between pY and pT.  
As can be seen in the HSQC spectrum overlay in Fig. 4, single mutation of 
tyrosine (378 or 397) or threonine 348 partially impaired the SH3/PR binding. The 
relative distance between the crosspeaks in the mutants and in bound SH3 domain 
[i.e. construct #1(WT)] correlates well with the ensemble weighted average of the 
unbound SH3 population. Therefore we conclude from Fig. 4 that the phosphorylation 
mimics breaks the PR-SH3 binding to some extent. The T348D mutation showed 
greater effect than the tyrosine mutations, which can be told by larger recovery of the 
binding residues to their isolated form. 
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The extra Glu-Pro repeats interfere with SH3/PR binding in HS1 
 Otsuka et al reported that the frequency of (Glu-Pro)2 insertion between codons 
366 and 367 of HS1 protein was statistically significantly higher in SLE patients than 
in healthy controls (Otsuka et al., 2004). It could be the case that some 
conformational change caused by the extra Glu-Pro dipeptides eliminates the binding 
between HS1 SH3 domain and its PR. We therefore made HS1 truncated mutant 
constructs #1(SLE), #2(SLE) and #3(SLE) (Fig. 1), obtained HSQC spectra and 
overlaid chemical shifts with the isolated SH3 domain and with the wild-type HS1 
truncated constructs #1(WT), #2(WT) and #3(WT) (Fig. 4b). Like the T348, Y378 and 
Y397 mutants, the SLE disease mutations also interfered with the PR-SH3 binding. 
Compared to the spectra in Fig. 4a, there is more percentage of SH3 in the bound 
form, indicating that the SLE mutations disrupt the PR-SH3 binding at a less level 
than the threonine and tyrosine phosphorylation mimics. 
 
DISCUSSION 
Domain interactions play key roles in signal transductions, and delicate control on 
domain interactions is critical in many cellular processes. The PR and SH3 domain of 
HS1 proteins are binding motifs for other signaling molecules. HS1 PR binds to Lck 
that together with ZAP-70 are required for the phosphorylation of Tyr 378 and Tyr 397. 
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The SH3 domain binds to HS1BP3 (Takemoto et al., 1999), and its homologue 
cortactin SH3 domain binds to WIP, which catalyzes actin filament formation together 
with WASp (Daly, 2004). Therefore it could be possible that HS1 SH3 domain also 
binds to WIP.  
Autoinhibition is widely used in nature to repress otherwise constitutive activation 
of proteins involved in a diverse set of biological phenomena, including signaling, 
transcription, and transport (Kobe and Kemp, 1999; Aghazadeh et al., 2000; 
Blume-Jensen and Hunter, 2001; Huse and Kuriyan, 2002; Pufall and Graves, 2002; 
Schlessinger, 2003; Reindl and Spiekermann, 2006; Sarkar et al., 2007). The 
self-interaction between HS1 SH3 domain and its PR may serve as a strategy of 
autoinhibition that prevents or at least decreases the binding of HS1 or PR to their 
signaling binding partners (See the model in Fig. 5). The interaction between the SH3 
domain and PR is an intramolecular one, and will increase the local concentration of 
the two binding motifs and hence produce stronger autoinhibition. 
HS1 is a major target for tyrosine phosphorylation after immunoreceptor ligation 
(Yamanashi et al., 1993; Takemoto et al., 1995; Hutchcroft et al., 1998). The tyrosine 
phosphorylation is required for HS1 recruitment to immune synapse (Gomez et al., 
2006). Serine and threonine phosphorylations have not been reported in HS1 but in 
cortactin. According to our model (Fig. 5), the binding partners for SH3 domain and 
for PR have to compete against this self-association, which could be tight without 
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tyrosine and threonine phosphorylations. Phosphorylation functions to switch on the 
activity of HS1 protein by breaking up the autoinhibitory binding between SH3 and PR, 
thus creating new binding sites for other proteins such as Lck, HS1BP3 and possibly 
WIP. In the identified Lupus allele of HS1, the HS1 protein is not completely switched 
off by the putative autoinhibitory SH3/PR binding, so HS1 can’t be delicately 
regulated by Erk and Src kinases. Here we have generated a model for HS1 
regulation from in vitro experiment results. More cellular work is needed to test in real 
biological system.  
 
MATERIALS AND METHODS 
Cloning of HS1 Constructs. HS1 SH3 domain was cloned in pGEX-4T-1 vector, 
and all other HS1 fragments were cloned in pET24b vector with a His tag at 
C-terminal for production and purification from bacteria. The PR mutants were 
mutated as follows: PRM1 (P342A, P345A and R347A), PRM2 (P326A, P329A and 
R331A), PRM3 (P304A, P305A, P309A and P310A) and PRM4 (P288A, P291A and 
P293A). All mutations were made using the site-directed mutagenesis kit 
(Stratagene). All constructs were verified by sequencing at the Iowa State University 
DNA Synthesis and Sequencing Facility.  
Expression and Purification of HS1 Constructs. The plasmids encoding HS1 
constructs were transformed into BL21 DE3 E. coli and the bacteria grew in minimal 
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medium where 15NH4Cl was the only nitrogen source. 1 mM IPTG was added to the 
bacteria culture and the proteins were expressed at 15 oC. The bacteria pellets were 
harvested at 6000 rpm centrifugation, resuspended in PBS buffer (pH 7.0, 150 mM 
NaCl), added with 5 mg/mL lysozyme and frozen in -80 oC. The pellet was thawed at 
room temperature, added with 1 mM PMSF and DNase. The supernatant was applied 
to affinity chromatography (glutathione beads or Ni-beads, Novagen) after 
centrifugation at 16000 rpm. The resins were washed with 200 mL PBS buffer and 
then the proteins were eluted off the beads. For HS1 SH3 domain, cleavage was 
done with 40 U/mL thrombin at room temperature for 15 hours. Then glutathione 
beads were used again for getting rid of cleaved GST. Buffer change was done by 
concentrating and refilling the protein solutions for 3 times. Finally the protein 
samples were concentrated for NMR use. 
NMR Experiments. NMR spectra were recorded at 25 oC on a Bruker AVII 700 
spectrometer equipped with a 5 mm HCN z-gradient cryoprobe operating at 700.133 
MHz 1H frequency. Phosphate buffer with 100 mM NaCl pH 7.0 was used for protein 
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Table 1. Truncated HS1 constructs containing SH3 domain 
Name Residues included Name Residues included 
SH3 G421 to C-end, wild-type #1(SLE)  E336 to C-end, (EP)8 
#1(WT)  E336 to C-end, wild-type #2(SLE)  S314 to C-end, (EP)8 
#2(WT)  S314 to C-end, wild-type #3(SLE)  E286 to C-end, (EP)8 
#3(WT)  E286 to C-end, wild-type #1(WT)-T348D Point mutation of #1(WT)
#1(WT)-Y378E  Point mutation of #1(WT) #1(WT)-Y397E  Point mutation of #1(WT)














Table 2. Line-width analysis for 5 resonances. 
Residue 
Number a 
Line-width (Hz) Residue 
Number a 
Line-width (Hz) 
#1(WT) #1(WT)-PRM #1(WT) #1(WT)-PRM 
1 16.156 16.515 C1 22.977 19.746 
2 17.592 17.233 C2 15.079 12.925 
3 15.438 14.720 C3 24.773 20.464 
4 18.310 17.951 C4 23.696 17.592 
5 17.233 16.874 C5 23.336 19.387 
 
Five peaks of unbound residues (1, 2, 3, 4 and 5), and five peaks of bound residues (C1, C2, C3, 
C4 and C5, “C” for control) were picked up from the HSQC spectra of the constructs #1(WT) and 
#1(WT)-PRM. The line-widths for each pairs of peaks were measured at half height of the peaks 
in 1H dimension.  
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Fig. 1. a) Domain structure of HS1 sequence studied in this thesis. The HS1 sequence interested 
in this thesis is the C-terminal of the HS1 protein, including four proline-rich regions and an SH3 
domain. A Glu-Pro dipeptide repeat sequence and two critical tyrosines are in the linker between 
PR and SH3 domain. The N-terminal starting residues for the truncated constructs #1, #2 and ＃
3 are shown in this figure. b) Amino acid sequence of the truncated HS1 protein shown in a). Four 
PRs are labeled in red; the Glu-Pro repeats are labeled in blue; the critical phosphorylation sites 



















Fig. 2. 15N-1H HSQC spectrum for the SH3 domain of HS1 protein. The NMR sample is in 











(a)           (b) 
  
Fig. 3. SH3 domain of HS1 interacts with its PR, and the Lupus disease mutants interfere with this 
interaction. (a) Spectrum overlay for SH3, #1(WT), #2(WT) and #3(WT) constructs of HS1 protein. 
Black: SH3 domain alone; dark blue: #1(WT); dark green: #2(WT); dark red: #3(WT). (b) PR1 
mutant breaks up SH3/PR interaction. Black: SH3 domain alone; red: #1(WT)-PRM; dark blue: 











(a)              (b) 
 
Fig. 4. (a) Phosphorylation of T348, Y378 and Y397 breaks up SH3/PR binding. Black: SH3 
domain alone; dark blue: #1(WT); purple: #1(WT)-T348D; red: #1(WT)-Y378E; orange: 
#1(WT)-Y397E. (b) Spectrum overlay for SH3, #1(WT), #1(SLE), #2(WT), #2(SLE), #3(WT) and 
#3(SLE) constructs of HS1 protein. Black: SH3 domain alone; dark blue: #1(WT); cyan: #1(SLE); 












Fig. 5. Tentative model of HS1 protein regulation by the SH3/PR auto-inhibitory binding. SH3 
domain of HS1 binds to its PR either by intramolecular or intermolecular interaction. Both the 
phosphorylation of T348, Y378 or Y397, and the Lupus disease mutant of HS1 protein with (EP)8 












CHAPTER 4. General Conclusion 
 
SUMMARY 
In my thesis we extended the study of CypA’s role in Itk regulation. We have 
found that CypA does not impair Itk kinase activity by simply blocking the kinase 
active site for an artificial peptide, peptide B. Instead CypA appears to interact with Itk 
kinase domain and SH2 domain directly and thus inhibits Y180 phosphorylation by Itk 
itself. NMR experiments demonstrate that the binding surface on the side of Itk SH2 
domain is in an α-helix and a loop region before this helix (V311 to N325). The 
interface on CypA part is on one side of the protein close to its active site. The 
interacting patches are rather hydrophobic for both binding partners. The precise 
mechanism of CypA inhibition is not known at this time. Whether CypA competes with 
substrate docking and perhaps also stabilizes an inactive conformation of Itk has yet 
to be determined. 
The hematopoietic lineage cell-specific protein HS1 is the leukocyte-specific 
homolog of cortactin. It promotes actin polymerization by bridging between Arp2/3 
complex and actin filaments and hence is required in cytoskeleton reorganization of T 
cells (Billadeau and Burkhardt, 2006; Gomez et al., 2006). The HS1 protein contains 
an N-terminal acidic region (NTA), a sequence of 37 amino acid tandem 
helix-turn-helix (HTH) repeats, a coiled-coil region, several proline-rich regions 
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(PRR’s) and a C-terminal SH3 domain (Hao et al., 2005). The SH3 domain and PRR 
of HS1 protein interact with other signaling molecules. The SH3 domain binds to 
HS1BP3 and possibly WASp-interacting protein (WIP). HS1 PRR binds to Lck, which 
is responsible for tyrosine phosphorylation on HS1.  
We have made several HS1 constructs all including SH3 domain, and 
demonstrated by NMR experiments that the SH3 domain of HS1 protein interacts 
with one of its multiple PRR’s (Pro 342 to Arg 345, which we named PRR1). Three 
phosphorylation sites lie between SH3 domain and PRR1. Phosphorylation of T348, 
Y378 and Y397 has been found to break the SH3/PRR binding. We hypothesize that 
the phosphorylation events, which are needed for HS1 recruitment to immune 
synapse, release free SH3 domain and PRR and hence trigger downstream signaling 
processes. We constructed HS1 fragments from an abnormal allele of Systemic 
Lupus Erythematosus (SLE), which has eight Glu-Pro dipeptide repeats instead of six 
repeats in normal HS1 protein. NMR data show that this disease mutation in HS1 
impairs the SH3/PRR binding to some degree but does not completely break it up. 
SLE is an autoimmune disease that can be fatal (Otsuka et al., 2004). Our tentative 
model supports the speculation that the SLE allele of HS1 protein is less self-inhibited 
and over-reactive, which leads to excessive actin polarization in T cells and hence 
autoimmune symptom.  
Overall this thesis provides molecular level insight into mechanisms of Itk 
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regulation by CypA and HS1 regulation through SH3/PRR binding. 
 
FUTURE DIRECTIONS 
Itk regulation by cyclophilin A 
 CypA binds to both SH2 domain and kinase domain of Itk. The interaction surface 
of CypA-SH2 binding has been mapped out by NMR, but that of CypA/KD binding is 
not known. The Itk kinase domain can be expressed in bacteria in large scale 
(Joseph and Andreotti, 2008), which will much facilitate the characterization of it 
using biophysical and biochemical methods, e.g. NMR, site-directed mutagenesis 
and pull-down assays. We have tried to map the surface on CypA by mutating 
surface exposed basic residues on CypA using functional kinase assays, and the 
results suggested that the binding patch on CypA might not be basic, so mutation on 
a broader range of surface residues should be explored. The binding surface on the 
kinase domain can be studied more easily with the information on the CypA 
interaction patch. The nature of the binding residues in CypA, once identified, should 
help guide mutagenesis of the larger kinase domain.  
Once we have characterized the binding of CypA with Itk and understand the 
molecular interface, we will make mutations on both proteins, transfect them into 
CypA-/- or Itk-/- mice, which are available, and will be able to test the effect in vivo. 
These experiments can be done in our collaborator Leslie Berg’s lab. On completion 
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of this project, we will have a developed model of how CypA regulates Itk and 
downstream signaling events in T cells. 
 
HS1 regulation through SH3/PRR interaction 
 We showed that there was an interaction between SH3 domain and PRR of HS1 
protein using NMR experiments. However we don’t know the exact binding surface 
on either side. The first thing we need to do is to assign the amino acid sequence of 
SH3 domain and PRR-SH3 truncated constructs of HS1 protein by NMR, so that we 
can know which residues exactly participate in the interaction. As well, three 
dimensional NMR structure of the HS1 SH3 domain needs to be solved. 
Cellular work is also needed to examine how the SH3/PRR interaction regulates 
HS1 function in a biological system. It will be informative to check the change in SH3 
mediated binding and that of actin polarization after injecting mutant HS1 gene into 
HS1-/- T cells.  
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